Beyond biologics: is there a role for systemic cytotoxic chemotherapy in neuroendocrine tumors?-Reference-Cited by-同舟云学术

Beyond biologics: is there a role for systemic cytotoxic chemotherapy in neuroendocrine tumors?

Published:2015-03 Issue:1 Volume:2 Page:13-20
ISSN:2045-0869
Container-title:International Journal of Endocrine Oncology
language:en
Short-container-title:International Journal of Endocrine Oncology

Author:

Narayanan Sujata¹,Kunz Pamela L¹

Affiliation:

1. Stanford University School of Medicine, Stanford Cancer Center, 875 Blake Wilbur Drive, Stanford, CA 94305–5826, USA

Abstract

Abstract: Neuroendocrine tumors (NETs) are a group of biologically and clinically heterogeneous neoplasms that have varying degrees of responsiveness to systemic and targeted therapies. With recent advances in therapeutics, a number of biologic therapies have been incorporated into the management of NETs. In this review, we discuss the role of cytotoxic chemotherapy in the management of NETs with an overview of past and present clinical trials, current treatment guidelines and future directions.

Publisher

Future Medicine Ltd

Subject

Cancer Research,Endocrinology,Oncology,Endocrinology, Diabetes and Metabolism

Link

https://www.futuremedicine.com/doi/pdf/10.2217/ije.14.37

Reference49 articles.

1. The Epidemiology of Gastroenteropancreatic Neuroendocrine Tumors

2. One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States

3. Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE)

4. Gastrointestinal carcinoid: epidemiological and survival evidence from a large population-based study (n = 25 531)

5. The Pathologic Classification of Neuroendocrine Tumors

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management Options for Advanced Low or Intermediate Grade Gastroenteropancreatic Neuroendocrine Tumors: Review of Recent Literature;International Journal of Surgical Oncology;2017